10-K Filing

IOVANCE BIOTHERAPEUTICS, INC. CIK: 1425205 FY 2013

Filing Information

Form Type	10-K
Accession Number	`0001513160-14-000023`
Period End Date	20131231
Filing Date	20140328
Fiscal Year	2013
Fiscal Period	FY
XBRL Instance	gnpb-20131231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 67 Income Statement 59 Cash Flow Statement 130 Stockholders Equity 52

Balance Sheet 67 line items

Line Item	Tag	Value	Unit	Period
Property and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$16.00K	USD	Point-in-time
Cash and cash equivalents	`Cash`	-	USD	Point-in-time
Cash and cash equivalents	`Cash`	$19.67M	USD	Point-in-time
Property and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$8.91K	USD	Point-in-time
Deposits	`PrepaidExpenseAndOtherAssetsCurrent`	$15.00K	USD	Point-in-time
Deposits	`PrepaidExpenseAndOtherAssetsCurrent`	$5.00K	USD	Point-in-time
Preferred Stock Par Value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$158.72K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$2.27K	USD	Point-in-time
Preferred Stock Par Value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$19.85M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$7.28K	USD	Point-in-time
Preferred Stock Authorized	`PreferredStockSharesAuthorized`	50.00M	shares	Point-in-time
Preferred Stock Authorized	`PreferredStockSharesAuthorized`	50.00M	shares	Point-in-time
Preferred Stock Issued	`PreferredStockSharesIssued`	17,000.00	shares	Point-in-time
Property and equipment, net of accumulated depreciation of $16,002 and $8,915	`PropertyPlantAndEquipmentNet`	$22.14K	USD	Point-in-time
Property and equipment, net of accumulated depreciation of $16,002 and $8,915	`PropertyPlantAndEquipmentNet`	$27.76K	USD	Point-in-time
Preferred Stock Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred Stock Outstanding	`PreferredStockSharesOutstanding`	17,000.00	shares	Point-in-time
Total assets	`Assets`	$19.87M	USD	Point-in-time
Total assets	`Assets`	$29.41K	USD	Point-in-time
Common Stock Par Value	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Common Stock Par Value	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Common Stock Shares Authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common Stock Shares Authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.10M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$412.98K	USD	Point-in-time
Accrued expenses	`InterestPayableCurrent`	$1.86M	USD	Point-in-time
Common Stock Shares Issued	`CommonStockSharesIssued`	20.02M	shares	Point-in-time
Common Stock Shares Issued	`CommonStockSharesIssued`	818,806.00	shares	Point-in-time
Accrued expenses	`InterestPayableCurrent`	$1.74M	USD	Point-in-time
Common Stock Shares Outstanding	`CommonStockSharesOutstanding`	20.02M	shares	Point-in-time
Common Stock Shares Outstanding	`CommonStockSharesOutstanding`	818,806.00	shares	Point-in-time
7% Senior secured convertible promissory notes	`ConvertibleNotesPayableCurrent`	$5.00M	USD	Point-in-time
7% Senior secured convertible promissory notes	`ConvertibleNotesPayableCurrent`	-	USD	Point-in-time
12% secured promissory notes	`SecuredPromissoryNotes`	$1.23M	USD	Point-in-time
12% secured promissory notes	`SecuredPromissoryNotes`	-	USD	Point-in-time
Common stock to be issued	`CommonStockToBeIssued`	303,125.00	shares	Point-in-time
Common stock to be issued	`CommonStockToBeIssued`	0.00	shares	Point-in-time
September 2012 secured promissory note	`SecuredDebtCurrent`	$250.00K	USD	Point-in-time
September 2012 secured promissory note	`SecuredDebtCurrent`	-	USD	Point-in-time
Accrued interest and penalty	`AccruedInterestAndPenalty`	$2.03M	USD	Point-in-time
Accrued interest and penalty	`AccruedInterestAndPenalty`	-	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$2.27M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$11.35M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 50,000,000 shares authorized, 17,000 shares and no shares issued and outstanding, respectively	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 50,000,000 shares authorized, 17,000 shares and no shares issued and outstanding, respectively	`PreferredStockValue`	$17.00	USD	Point-in-time
Common stock, $0.000041666 par value; 18,000,000 shares authorized, 20,023,958 and 818,806 shares issued and outstanding, respectively	`CommonStockValue`	$835.00	USD	Point-in-time
Common stock, $0.000041666 par value; 18,000,000 shares authorized, 20,023,958 and 818,806 shares issued and outstanding, respectively	`CommonStockValue`	$34.00	USD	Point-in-time
Common shares to be issued, 303,125 shares	`CommonSharesToBeIssuedWith12SecuredPromissoryNotes`	$245.15K	USD	Point-in-time
Common shares to be issued, 303,125 shares	`CommonSharesToBeIssuedWith12SecuredPromissoryNotes`	$245.15K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$19.12M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$81.88M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-64.53M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-30.68M	USD	Point-in-time
Total Stockholders' Equity (Deficiency)	`StockholdersEquity`	$638.09K	USD	Point-in-time
Total Stockholders' Equity (Deficiency)	`StockholdersEquity`	$-11.32M	USD	Point-in-time
Total Stockholders' Equity (Deficiency)	`StockholdersEquity`	$2.28K	USD	Point-in-time
Total Stockholders' Equity (Deficiency)	`StockholdersEquity`	$-12.78M	USD	Point-in-time
Total Stockholders' Equity (Deficiency)	`StockholdersEquity`	$-13.49K	USD	Point-in-time
Total Stockholders' Equity (Deficiency)	`StockholdersEquity`	$8.00K	USD	Point-in-time
Total Stockholders' Equity (Deficiency)	`StockholdersEquity`	$17.60M	USD	Point-in-time
Total Liabilities and Stockholders' Equity (Deficiency)	`LiabilitiesAndStockholdersEquity`	$29.41K	USD	Point-in-time
Total Liabilities and Stockholders' Equity (Deficiency)	`LiabilitiesAndStockholdersEquity`	$19.87M	USD	Point-in-time

Income Statement 59 line items

Line Item	Tag	Value	Unit	Period
Revenues	`SalesRevenueGoodsNet`	-	USD	Annual
Revenues	`SalesRevenueGoodsNet`	-	USD	24 Qtrs
Revenues	`SalesRevenueGoodsNet`	-	USD	Annual
Share-Based Compensation	`ShareBasedCompensation`	$10.14M	USD	24 Qtrs
Share-Based Compensation	`ShareBasedCompensation`	$2.75M	USD	Annual
Share-Based Compensation	`ShareBasedCompensation`	$2.53M	USD	Annual
Operating expenses (including $2,750,223, $2,528,254 and $10,138,952 of non-cash share-based compensation costs)	`OperatingCostsAndExpenses`	$6.48M	USD	Annual
Operating expenses (including $2,750,223, $2,528,254 and $10,138,952 of non-cash share-based compensation costs)	`OperatingCostsAndExpenses`	$31.15M	USD	24 Qtrs
Operating expenses (including $2,750,223, $2,528,254 and $10,138,952 of non-cash share-based compensation costs)	`OperatingCostsAndExpenses`	$4.66M	USD	Annual
Cost of Lion transaction - related party	`CostOfLionTransaction`	-	USD	Annual
Cost of Lion transaction - related party	`CostOfLionTransaction`	$16.66M	USD	Annual
Cost of Lion transaction - related party	`CostOfLionTransaction`	$16.66M	USD	24 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$4.91M	USD	24 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.33M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$1.66M	USD	Annual
Impairment of intangible asset	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$160.04K	USD	24 Qtrs
Impairment of intangible asset	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	Annual
Impairment of intangible asset	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	Annual
Total costs and expenses	`OperatingExpenses`	$22.64M	USD	Annual
Total costs and expenses	`OperatingExpenses`	$52.88M	USD	24 Qtrs
Total costs and expenses	`OperatingExpenses`	$8.13M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-8.13M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-22.64M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-52.88M	USD	24 Qtrs
Interest expense	`InterestIncomeExpenseNet`	$-1.92M	USD	Annual
Interest expense	`InterestIncomeExpenseNet`	$-2.52M	USD	24 Qtrs
Interest expense	`InterestIncomeExpenseNet`	$-444.73K	USD	Annual
Change in fair value of derivative liabilities	`DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet`	$10.00M	USD	24 Qtrs
Change in fair value of derivative liabilities	`DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet`	$8.64M	USD	Annual
Change in fair value of derivative liabilities	`DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet`	-	USD	Annual
Amortization of discount on convertible notes	`AmortizationOfDebtDiscountPremium`	-	USD	Annual
Amortization of discount on convertible notes	`AmortizationOfDebtDiscountPremium`	$5.50M	USD	24 Qtrs
Amortization of discount on convertible notes	`AmortizationOfDebtDiscountPremium`	$497.89K	USD	Annual
Cost to induce exchange transaction	`CostToInduceExchangeTransaction`	$2.30M	USD	Annual
Cost to induce exchange transaction	`CostToInduceExchangeTransaction`	$2.30M	USD	24 Qtrs
Cost to induce exchange transaction	`CostToInduceExchangeTransaction`	-	USD	Annual
Financing costs	`AmortizationOfFinancingCosts`	$1.39M	USD	Annual
Financing costs	`AmortizationOfFinancingCosts`	$2.87M	USD	24 Qtrs
Financing costs	`AmortizationOfFinancingCosts`	-	USD	Annual
Total other income (expense)	`OtherNonoperatingIncomeExpense`	$4.82M	USD	Annual
Total other income (expense)	`OtherNonoperatingIncomeExpense`	$-2.74M	USD	Annual
Total other income (expense)	`OtherNonoperatingIncomeExpense`	$-3.18M	USD	24 Qtrs
Net Loss	`NetIncomeLoss`	$-56.07M	USD	24 Qtrs
Net Loss	`NetIncomeLoss`	$-15.77K	USD	Annual
Net Loss	`NetIncomeLoss`	$-25.69M	USD	Annual
Net Loss	`NetIncomeLoss`	$-1.61M	USD	Annual
Net Loss	`NetIncomeLoss`	$-25.38M	USD	Annual
Net Loss	`NetIncomeLoss`	$-58.72K	USD	5 Qtrs
Net Loss	`NetIncomeLoss`	$-3.31M	USD	Annual
Deemed dividend related to beneficial conversion feature of convertible preferred stock	`OtherPreferredStockDividendsAndAdjustments`	-	USD	Annual
Deemed dividend related to beneficial conversion feature of convertible preferred stock	`OtherPreferredStockDividendsAndAdjustments`	$-8.46M	USD	24 Qtrs
Deemed dividend related to beneficial conversion feature of convertible preferred stock	`OtherPreferredStockDividendsAndAdjustments`	$-8.46M	USD	Annual
Net Loss Attributable to Common Stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-33.84M	USD	Annual
Net Loss Attributable to Common Stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-64.53M	USD	24 Qtrs
Net Loss Attributable to Common Stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-3.31M	USD	Annual
Net Loss Per Share Attributable to Common Stockholders, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-4.14	USD	Annual
Net Loss Per Share Attributable to Common Stockholders, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-3.47	USD	Annual
Weighted-Average Common Shares Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	798,530.00	shares	Annual
Weighted-Average Common Shares Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	9.76M	shares	Annual

Cash Flow Statement 130 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-56.07M	USD	24 Qtrs
Net loss	`NetIncomeLoss`	$-15.77K	USD	Annual
Net loss	`NetIncomeLoss`	$-25.69M	USD	Annual
Net loss	`NetIncomeLoss`	$-1.61M	USD	Annual
Net loss	`NetIncomeLoss`	$-25.38M	USD	Annual
Net loss	`NetIncomeLoss`	$-58.72K	USD	5 Qtrs
Net loss	`NetIncomeLoss`	$-3.31M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$7.09K	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$6.21K	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$77.37K	USD	24 Qtrs
Impairment of intangible asset	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$160.04K	USD	24 Qtrs
Impairment of intangible asset	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	Annual
Impairment of intangible asset	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	Annual
Fair value of vested stock options and warrants	`StockOptionPlanExpense`	$747.24K	USD	Annual
Fair value of vested stock options and warrants	`StockOptionPlanExpense`	$5.18M	USD	24 Qtrs
Fair value of vested stock options and warrants	`StockOptionPlanExpense`	$2.53M	USD	Annual
Fair value of common stock and warrants accounted for as financing costs	`FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts`	-	USD	Annual
Fair value of common stock and warrants accounted for as financing costs	`FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts`	-	USD	Annual
Fair value of common stock and warrants accounted for as financing costs	`FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts`	$2.99M	USD	24 Qtrs
Fair value of vested warrants granted for services	`FairValueOfVestedWarrantsGrantedForServices`	-	USD	Annual
Fair value of vested warrants granted for services	`FairValueOfVestedWarrantsGrantedForServices`	-	USD	Annual
Fair value of vested warrants granted for services	`FairValueOfVestedWarrantsGrantedForServices`	$2.56M	USD	24 Qtrs
Amortization of discount on convertible notes	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-497.89K	USD	Annual
Amortization of discount on convertible notes	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-5.00M	USD	24 Qtrs
Amortization of discount on convertible notes	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	-	USD	Annual
Private placement costs	`PrivatePlacementCosts1`	$385.00K	USD	24 Qtrs
Private placement costs	`PrivatePlacementCosts1`	$515.27K	USD	Annual
Private placement costs	`PrivatePlacementCosts1`	-	USD	Annual
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$10.00M	USD	24 Qtrs
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$8.64M	USD	Annual
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	-	USD	Annual
Common stock issued to officer for services	`CommonStockIssuedToOfficerForServices`	-	USD	Annual
Common stock issued to officer for services	`CommonStockIssuedToOfficerForServices`	-	USD	Annual
Common stock issued to officer for services	`CommonStockIssuedToOfficerForServices`	$8.01M	USD	24 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$274.00K	USD	Annual
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$1.57M	USD	24 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$800.00K	USD	Annual
Common stock issued to induce conversion of warrants	`CommonStockIssuedToInduceConversionOfWarrants`	$122.73K	USD	Annual
Common stock issued to induce conversion of warrants	`CommonStockIssuedToInduceConversionOfWarrants`	-	USD	Annual
Common stock issued to induce conversion of warrants	`CommonStockIssuedToInduceConversionOfWarrants`	$122.73K	USD	24 Qtrs
Common stock issued to induce exchange transaction	`CommonStockIssuedToInduceExchangeTransaction`	$2.17M	USD	Annual
Common stock issued to induce exchange transaction	`CommonStockIssuedToInduceExchangeTransaction`	$2.17M	USD	24 Qtrs
Common stock issued to induce exchange transaction	`CommonStockIssuedToInduceExchangeTransaction`	$875.00K	USD	Annual
Common stock issued for Lion transaction	`CommonStockIssuedforLionTransaction`	$16.66M	USD	Annual
Common stock issued for Lion transaction	`CommonStockIssuedforLionTransaction`	-	USD	Annual
Common stock issued for Lion transaction	`CommonStockIssuedforLionTransaction`	$16.66M	USD	24 Qtrs
Common stock issued to directors	`CommonStockIssuedtoDirectors`	-	USD	Annual
Common stock issued to directors	`CommonStockIssuedtoDirectors`	$2.00M	USD	Annual
Common stock issued to directors	`CommonStockIssuedtoDirectors`	$2.00M	USD	24 Qtrs
Fair value of common stock transferred to officer and director	`FairValueOfCommonStockTransferredToOfficerAndDirector`	-	USD	Annual
Fair value of common stock transferred to officer and director	`FairValueOfCommonStockTransferredToOfficerAndDirector`	-	USD	Annual
Fair value of common stock transferred to officer and director	`FairValueOfCommonStockTransferredToOfficerAndDirector`	$1.74M	USD	24 Qtrs
Write off of advances to related party	`WriteOffOfAdvancesToRelatedParty`	-	USD	Annual
Write off of advances to related party	`WriteOffOfAdvancesToRelatedParty`	$50.00K	USD	24 Qtrs
Write off of advances to related party	`WriteOffOfAdvancesToRelatedParty`	-	USD	Annual
Deposits, prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$166.44K	USD	Annual
Deposits, prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$173.72K	USD	24 Qtrs
Deposits, prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-22.59K	USD	Annual
Accounts payable, accrued expenses and interest and penalty	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-543.56K	USD	Annual
Accounts payable, accrued expenses and interest and penalty	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$2.58M	USD	Annual
Accounts payable, accrued expenses and interest and penalty	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$2.29M	USD	24 Qtrs
Accrued interest and penalty	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$2.47M	USD	24 Qtrs
Accrued interest and penalty	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$445.74K	USD	Annual
Accrued interest and penalty	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$1.88M	USD	Annual
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.24M	USD	Annual
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-12.79M	USD	24 Qtrs
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.66M	USD	Annual
Purchases of computer equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$12.71K	USD	Annual
Purchases of computer equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$47.76K	USD	24 Qtrs
Purchases of computer equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	Annual
Advances to related party	`PaymentsToFundLongtermLoansToRelatedParties`	-	USD	Annual
Advances to related party	`PaymentsToFundLongtermLoansToRelatedParties`	$50.00K	USD	24 Qtrs
Advances to related party	`PaymentsToFundLongtermLoansToRelatedParties`	-	USD	Annual
Net Cash Used In Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$-12.71K	USD	Annual
Net Cash Used In Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	Annual
Net Cash Used In Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$-97.76K	USD	24 Qtrs
Proceeds from the issuance of convertible notes, net	`ProceedsFromConvertibleDebt`	$4.93M	USD	24 Qtrs
Proceeds from the issuance of convertible notes, net	`ProceedsFromConvertibleDebt`	$311.50K	USD	Annual
Proceeds from the issuance of convertible notes, net	`ProceedsFromConvertibleDebt`	-	USD	Annual
Proceeds from the issuance of secured promissory notes, net	`ProceedsFromIssuanceOfSecuredPromissoryNotesNet`	-	USD	Annual
Proceeds from the issuance of secured promissory notes, net	`ProceedsFromIssuanceOfSecuredPromissoryNotesNet`	$1.48M	USD	24 Qtrs
Proceeds from the issuance of secured promissory notes, net	`ProceedsFromIssuanceOfSecuredPromissoryNotesNet`	$1.48M	USD	Annual
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	$10.22M	USD	24 Qtrs
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	$7.13M	USD	Annual
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	$250.00K	USD	Annual
Proceeds from the issuance of preferred stock, net	`ProceedsFromIssuanceOfPreferredStockAndPreferenceStock`	$15.91M	USD	24 Qtrs
Proceeds from the issuance of preferred stock, net	`ProceedsFromIssuanceOfPreferredStockAndPreferenceStock`	-	USD	Annual
Proceeds from the issuance of preferred stock, net	`ProceedsFromIssuanceOfPreferredStockAndPreferenceStock`	$15.91M	USD	Annual
Due to director	`IncreaseDecreaseInDueToOfficersAndStockholders`	$18.14K	USD	24 Qtrs
Due to director	`IncreaseDecreaseInDueToOfficersAndStockholders`	-	USD	Annual
Due to director	`IncreaseDecreaseInDueToOfficersAndStockholders`	-	USD	Annual
Net Cash Provided By Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$23.35M	USD	Annual
Net Cash Provided By Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$1.73M	USD	Annual
Net Cash Provided By Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$32.56M	USD	24 Qtrs
Net Increase/(Decrease) In Cash And Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-510.22K	USD	Annual
Net Increase/(Decrease) In Cash And Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$19.67M	USD	Annual
Net Increase/(Decrease) In Cash And Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$19.67M	USD	24 Qtrs
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$510.22K	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$19.67M	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$510.22K	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$19.67M	USD	Point-in-time
Derivative liability recorded upon issuance of convertible notes and warrants	`DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants`	$5.54M	USD	24 Qtrs
Derivative liability recorded upon issuance of convertible notes and warrants	`DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants`	-	USD	Annual
Derivative liability recorded upon issuance of convertible notes and warrants	`DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants`	-	USD	Annual
Derivative liability recorded as offering cost	`DerivativeLiabilityRecordedAsPrivatePlacementCost`	$697.35K	USD	Annual
Derivative liability recorded as offering cost	`DerivativeLiabilityRecordedAsPrivatePlacementCost`	$1.90M	USD	24 Qtrs
Derivative liability recorded as offering cost	`DerivativeLiabilityRecordedAsPrivatePlacementCost`	-	USD	Annual
Common stock issued for intellectual property	`StockIssued1`	-	USD	Annual
Common stock issued for intellectual property	`StockIssued1`	$217.41K	USD	24 Qtrs
Common stock issued for intellectual property	`StockIssued1`	-	USD	Annual
Forgiveness of debt by director, treated as contribution of capital	`DebtInstrumentDecreaseForgiveness`	-	USD	Annual
Forgiveness of debt by director, treated as contribution of capital	`DebtInstrumentDecreaseForgiveness`	-	USD	Annual
Forgiveness of debt by director, treated as contribution of capital	`DebtInstrumentDecreaseForgiveness`	$18.14K	USD	24 Qtrs
Forgiveness of debt by director, treated as contribution of capital	`DebtInstrumentDecreaseForgiveness`	$18.14K	USD	Annual
Common stock issued upon conversion of convertible notes	`DebtConversionOriginalDebtAmount1`	$6.79M	USD	24 Qtrs
Common stock issued upon conversion of convertible notes	`DebtConversionOriginalDebtAmount1`	$6.79M	USD	Annual
Common stock issued upon conversion of convertible notes	`DebtConversionOriginalDebtAmount1`	-	USD	Annual
Fair value of common stock issued with notes payable recorded as a note discount	`FairValueOfCommonStockIssuedWithNotesPayableRecordedAsNoteDiscount`	-	USD	Annual
Fair value of common stock issued with notes payable recorded as a note discount	`FairValueOfCommonStockIssuedWithNotesPayableRecordedAsNoteDiscount`	$497.89K	USD	24 Qtrs
Fair value of common stock issued with notes payable recorded as a note discount	`FairValueOfCommonStockIssuedWithNotesPayableRecordedAsNoteDiscount`	$497.89K	USD	Annual
Settlement of accounts payable through issuance of common stock	`SettlementOfAccountsPayableThroughIssuanceOfCommonStock`	$25.00K	USD	24 Qtrs
Settlement of accounts payable through issuance of common stock	`SettlementOfAccountsPayableThroughIssuanceOfCommonStock`	$25.00K	USD	Annual
Settlement of accounts payable through issuance of common stock	`SettlementOfAccountsPayableThroughIssuanceOfCommonStock`	-	USD	Annual
Common stock issued upon conversion of accrued interest and penalty	`CommonStockIssuedUponConversionOfAccruedInterestAndPenalty`	-	USD	Annual
Common stock issued upon conversion of accrued interest and penalty	`CommonStockIssuedUponConversionOfAccruedInterestAndPenalty`	$2.47M	USD	24 Qtrs
Common stock issued upon conversion of accrued interest and penalty	`CommonStockIssuedUponConversionOfAccruedInterestAndPenalty`	$2.47M	USD	Annual

Stockholders Equity 52 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance Amount	`StockholdersEquity`	$638.09K	USD	Point-in-time
Beginning Balance Amount	`StockholdersEquity`	$-11.32M	USD	Point-in-time
Beginning Balance Amount	`StockholdersEquity`	$2.28K	USD	Point-in-time
Beginning Balance Amount	`StockholdersEquity`	$-12.78M	USD	Point-in-time
Beginning Balance Amount	`StockholdersEquity`	$-13.49K	USD	Point-in-time
Beginning Balance Amount	`StockholdersEquity`	$8.00K	USD	Point-in-time
Beginning Balance Amount	`StockholdersEquity`	$17.60M	USD	Point-in-time
Private placement, amount	`StockIssuedDuringPeriodValueOther`	$1.91M	USD	Annual
Private placement, amount	`StockIssuedDuringPeriodValueOther`	$67.92K	USD	Annual
Private placement, amount	`StockIssuedDuringPeriodValueOther`	$21.80M	USD	Annual
Private placement, amount	`StockIssuedDuringPeriodValueOther`	$53.00K	USD	5 Qtrs
Common stock issued to induce exchange transaction, amount	`CommonStockIssuedToInduceExchangeTransactionAmount`	$2.17M	USD	Annual
Common stock issued for intellectual property, amount	`StockIssuedDuringPeriodValuePurchaseOfAssets`	$217.41K	USD	Annual
Common stock and warrant sold in private placement at $1.00 per share, April to June 2011, net of fair value of warrant derivative, amount	`CommonStockAndWarrantSoldInPrivatePlacementAt1.00PerShareAprilToJune2011NetOfFairValueOfWarrantDerivativeAmount`	$185.70K	USD	Annual
Common stock issued for cash under the restructuring, net of offering costs of $109,990, amount	`CommonStockIssuedForCashUnderRestructuringNetOfOfferingCostsOf109990Amount`	$1.24M	USD	Annual
Forgiveness of debt by director	`DebtInstrumentDecreaseForgiveness`	-	USD	Annual
Forgiveness of debt by director	`DebtInstrumentDecreaseForgiveness`	-	USD	Annual
Forgiveness of debt by director	`DebtInstrumentDecreaseForgiveness`	$18.14K	USD	24 Qtrs
Forgiveness of debt by director	`DebtInstrumentDecreaseForgiveness`	$18.14K	USD	Annual
Common stock issued in settlement of notes payable and accrued interest and penalty, amount	`CommonStockIssuedInSettlementOfNotesPayableAndAccruedInterestAndPenaltyAmount`	$9.27M	USD	Annual
Fair value of common stock issued for cancellation of outstanding warrants, amount	`FairValueOfCommonStockIssuedForCancellationOfOutstandingWarrantsAmount`	$122.73K	USD	Annual
Common stock issued for Lion transaction, Amount	`CommonStockIssuedForLionTransactionAmount`	$16.66M	USD	Annual
Common stock issued to directors, Amount	`CommonStockIssuedToDirectorsAmount`	$2.00M	USD	Annual
Common stock issued for settlement of payable, Amount	`CommonStockIssuedForSettlementOfPayableAmount`	$25.00K	USD	Annual
Fair value of common stock issued to consultatnt for services, Amount	`FairValueOfCommonStockIssuedToConsultatntForServicesAmount`	$800.00K	USD	Annual
Common stock issued to consultants for services, Amount	`CommonStockIssuedToConsultantsForServicesAmount`	$498.45K	USD	Annual
Common stock issued to consultants for services, Amount	`CommonStockIssuedToConsultantsForServicesAmount`	$274.00K	USD	Annual
Cancellation of shares, Amount	`CancellationOfSharesAmount`	-	USD	Annual
Fair value of common stock issued to officer for services, Amount	`FairValueOfCommonStockIssuedToOfficerForServicesAmount`	$8.01M	USD	Annual
Fair value of common stock issued with notes payable recorded as a note discount, Amount	`FairValueOfCommonStockIssuedWithNotesPayableAmount`	$497.89K	USD	Annual
Fair value of common stock issued with notes payable recorded as financing cost, Amount	`FinancingCost`	$875.00K	USD	Annual
Fair value of vested stock options and warrants	`FairValueOfVestedStockOptionsAndWarrants`	$747.24K	USD	Annual
Fair value of vested stock options and warrants	`FairValueOfVestedStockOptionsAndWarrants`	$114.02K	USD	Annual
Fair value of vested stock options and warrants	`FairValueOfVestedStockOptionsAndWarrants`	$2.53M	USD	Annual
Fair value of vested stock options and warrants	`FairValueOfVestedStockOptionsAndWarrants`	$1.79M	USD	Annual
Fair value of common stock transferred to officer	`FairValueOfCommonStockTransferredToOfficer`	$702.04K	USD	Annual
Fair value of common stock transferred from CEO to a director	`FairValueOfCommonStockTransferredFromCeoToDirector`	$1.04M	USD	Annual
Deemed dividend on beneficial conversion feature of preferred stock, amount	`DeemedDividendOnBeneficialConversionFeatureOfPreferredStockAmount`	-	USD	Annual
Net loss	`NetIncomeLoss`	$-56.07M	USD	24 Qtrs
Net loss	`NetIncomeLoss`	$-15.77K	USD	Annual
Net loss	`NetIncomeLoss`	$-25.69M	USD	Annual
Net loss	`NetIncomeLoss`	$-1.61M	USD	Annual
Net loss	`NetIncomeLoss`	$-25.38M	USD	Annual
Net loss	`NetIncomeLoss`	$-58.72K	USD	5 Qtrs
Net loss	`NetIncomeLoss`	$-3.31M	USD	Annual
Ending Balance Amount	`StockholdersEquity`	$638.09K	USD	Point-in-time
Ending Balance Amount	`StockholdersEquity`	$-11.32M	USD	Point-in-time
Ending Balance Amount	`StockholdersEquity`	$2.28K	USD	Point-in-time
Ending Balance Amount	`StockholdersEquity`	$-12.78M	USD	Point-in-time
Ending Balance Amount	`StockholdersEquity`	$-13.49K	USD	Point-in-time
Ending Balance Amount	`StockholdersEquity`	$8.00K	USD	Point-in-time
Ending Balance Amount	`StockholdersEquity`	$17.60M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.